Insulin Market Research Report 2028 | Size, Share, Growth & Scope

Insulin Market Forecast to 2028 - Analysis by Type (Long Acting Insulin, Rapid Acting Insulins, Short acting Insulins and Traditional Human Insulins, Concentrated Insulins and Combination Insulins, Biosimilar Insulins, Glucagon-like peptide-1 (GLP-1), Pens and Needles, and Others), and Geography

Status : Published
Report Code : TIPRE00004051

Category : Life Sciences
No. of Pages : 186

Available Report Formats :

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Type, and Geography

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

Which region is dominating the insulin market?

The global insulin market based on regions is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In 2021, the North American region held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 12.7% during the forecast period

What are the restraining factors for the global insulin market worldwide?

Risks associated with insulin delivery devices are expected to restrict the insulin market growth during the forecast period.

What is insulin?

Insulin controls the body's fat and glucose metabolism. It is a peptide hormone that is secreted by beta cells in the islets of Langerhans in the pancreas and helps in glucose metabolism regulation. It promotes glucose to be absorbed from the blood by skeletal muscle cells and fat tissues. But due to some diseases and disorders body is not able to make a sufficient amount of insulin which results in hyperglycemia due to imbalanced metabolism. In such conditions, insulin is given externally to maintain normal blood glucose levels.

What are the driving factors for the global insulin market worldwide?

The factors driving the growth of the insulin market are the increase in the incidence of diabetes and rapid technological developments in insulin delivery devices by major players.

Who are the major players in the insulin market across the globe?

The insulin market majorly consists of the players, such as Eli Lilly and Company; Novo Nordisk A/S; Biocon; WOCKHARDT; Adocia; GlaxoSmithKline plc.; Sanofi; Pfizer Inc.; Merck & Co., Inc.; Tonghua Dongbao Pharmaceutical Co., Ltd.; BIGFOOT BIOMEDICAL, INC.; among others.

Which segment is dominating the insulin market?

The global insulin market based on type is segmented into long-acting insulin, rapid-acting insulin, short-acting insulin & traditional human insulin, concentrated insulin & combination insulin, biosimilar insulin, glucagonlike-peptide-1 (glp-1), pens & needles, and others. In 2021, the long-acting insulin segment held the largest share of the market. However, the biosimilar insulin segment of the insulin market is expected to register the highest CAGR of 16.0% during the forecast period.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Insulin Market – By Type

1.3.2 Global Insulin Market – By Geography

2. Insulin Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Insulin Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America– PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific– PEST Analysis

4.2.4 Middle East & Africa– PEST Analysis

4.2.5 South & Central America– PEST Analysis

4.2.6 Expert Opinion

5. Insulin Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Incidence of Diabetes

5.1.2 Rapid Technological Developments in Insulin Delivery Devices by Major Players

5.2 Market Restraints

5.2.1 Risks Associated with Insulin Delivery Devices

5.3 Market Opportunities

5.3.1 Insufficient Competition from Biosimilars

5.4 Future Trends

5.4.1 Regeneration of Diabetic Pancreas with Advanced Transplants

5.5 Impact Analysis

6. Insulin Market– Global Analysis

6.1 Global Insulin Market Revenue Forecast and Analysis

6.1.1 Global Insulin Market, By Geography - Forecast and Analysis

6.1.2 Global Insulin Market – Market Potential Analysis, By Region

6.2 Company Analysis

6.2.1 Market Positioning of Key Players

6.2.2 Comparative Company Analysis

6.2.3 Growth Strategy Analysis

6.2.4 Performance Of Key Players

6.2.4.1 Novo Nordisk A/S

6.2.4.2 Sanofi

6.2.4.3 Eli Lily and Company

6.3 Customization Part

6.3.1 Market Share Analysis by Company

6.3.2 Market Share by Injectable GLPs

7. Insulin Market Analysis – By Type

7.1 Overview

7.2 Insulin Market Revenue Share, by Type (2021 and 2028)

7.3 Long Acting Insulin

7.3.1 Overview

7.3.2 Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Levemir

7.3.2.1.1 Overview

7.3.2.1.2 Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Lantus

7.3.2.2.1 Overview

7.3.2.2.2 Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Basaglar

7.3.2.3.1 Overview

7.3.2.3.2 Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Tresiba

7.3.2.4.1 Overview

7.3.2.4.2 Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Rapid Acting Insulins

7.4.1 Overview

7.4.2 Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Novolog

7.4.2.1.1 Overview

7.4.2.1.2 Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Humalog

7.4.2.2.1 Overview

7.4.2.2.2 Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.3 Admelog

7.4.2.3.1 Overview

7.4.2.3.2 Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.4 Others

7.4.2.4.1 Overview

7.4.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Short Acting Insulins and Traditional Human Insulins

7.5.1 Overview

7.5.2 Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Novolin R

7.5.2.1.1 Overview

7.5.2.1.2 Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Humulin R

7.5.2.2.1 Overview

7.5.2.2.2 Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Insuman

7.5.2.3.1 Overview

7.5.2.3.2 Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.4 Others

7.5.2.4.1 Overview

7.5.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Concentrated Insulins and Combination Insulins

7.6.1 Overview

7.6.2 Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1 NovoMix

7.6.2.1.1 Overview

7.6.2.1.2 NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.2 Ryzodeg

7.6.2.2.1 Overview

7.6.2.2.2 Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.3 Xultophy

7.6.2.3.1 Overview

7.6.2.3.2 Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.4 Soliqua/Suliqua

7.6.2.4.1 Overview

7.6.2.4.2 Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Biosimilar Insulins

7.7.1 Overview

7.7.2 Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.1 Insulin Glargine

7.7.2.1.1 Overview

7.7.2.1.2 Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.2 Human Insulin

7.7.2.2.1 Overview

7.7.2.2.2 Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Glucagon-like peptide-1 (GLP-1)

7.8.1 Overview

7.8.2 Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Pens and Needles

7.9.1 Overview

7.9.2 Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.10 Others

7.10.1 Overview

7.10.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8. Global Insulin Market – Geographic Analysis

8.1 North America: Insulin Market

8.1.1 Overview

8.1.2 North America: Insulin market - Revenue and Forecast to 2028 (US$ Million)

8.1.3 North America: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.3.1 North America: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.3.2 North America: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.3.3 North America: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.3.4 North America: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.3.5 North America: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.4 North America: Insulin Market, by Country, 2021 & 2028 (%)

8.1.4.1 US: Global Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.4.1.1 US: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.4.1.2 US: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.4.1.2.1 US: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.4.1.2.2 US: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.4.1.2.3 US: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.4.1.2.4 US: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.4.1.2.5 US: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.4.2 Canada: Global Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.4.2.1 Canada: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.4.2.2 Canada: Insulin Market , By Type, 2019–2028 (US$ Million)

8.1.4.2.2.1 Canada: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.4.2.2.2 Canada: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.4.2.2.3 Canada: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.4.2.2.4 Canada: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.4.2.2.5 Canada: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.4.3 Mexico: Global Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.4.3.1 Mexico: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.4.3.2 Mexico: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.4.3.2.1 Mexico: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.4.3.2.2 Mexico: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.4.3.2.3 Mexico: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.4.3.2.4 Mexico: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.4.3.2.5 Mexico: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2 Europe: Insulin Market

8.2.1 Overview

8.2.2 Europe: Insulin Market - Revenue and Forecast to 2028 (US$ Million)

8.2.3 Europe: Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.3.1 Europe: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.3.2 Europe: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.3.3 Europe: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.3.4 Europe: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.3.5 Europe: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2.4 Europe: Insulin Market, by Country, 2021 & 2028 (%)

8.2.4.1 Germany: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.1.1 Germany: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.1.2 Germany: Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.4.1.2.1 Germany: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.4.1.2.2 Germany: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.4.1.2.3 Germany: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.4.1.2.4 Germany: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.4.1.2.5 Germany: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2.4.2 France: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.2.1 France: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.2.2 France : Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.4.2.2.1 France : Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.4.2.2.2 France : Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.4.2.2.3 France : Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.4.2.2.4 France : Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.4.2.2.5 France : Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2.4.3 UK: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.3.1 UK: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.3.2 UK: Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.4.3.2.1 UK: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.4.3.2.2 UK: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.4.3.2.3 UK: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.4.3.2.4 UK: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.4.3.2.5 UK: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2.4.4 Italy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.4.1 Italy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.4.2 Italy: Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.4.4.2.1 Italy: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.4.4.2.2 Italy: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.4.4.2.3 Italy: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.4.4.2.4 Italy: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.4.4.2.5 Italy: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2.4.5 Spain: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.5.1 Spain: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.5.2 Spain: Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.4.5.2.1 Spain: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.4.5.2.2 Spain: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.4.5.2.3 Spain: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.4.5.2.4 Spain: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.4.5.2.5 Spain: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.2.4.6 Rest of Europe: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.6.1 Rest of Europe: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4.6.2 Rest of Europe: Insulin Market, By Type, 2019–2028 (US$ Million)

8.2.4.6.2.1 Rest of Europe: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.2.4.6.2.2 Rest of Europe: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.2.4.6.2.3 Rest of Europe: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.2.4.6.2.4 Rest of Europe: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.2.4.6.2.5 Rest of Europe: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.3 Asia Pacific: Insulin Market

8.3.1 Overview

8.3.2 Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.3 Asia Pacific: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.3.1 Asia Pacific: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.3.2 Asia Pacific: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.3.3 Asia Pacific: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.3.4 Asia Pacific: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.3.5 Asia Pacific: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.3.4 Asia Pacific: Insulin Market, by Country, 2022 & 2028 (%)

8.3.4.1 China: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.1.1 China: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.1.2 China: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.4.1.2.1 China: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.4.1.2.2 China: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.4.1.2.3 China: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.4.1.2.4 China: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.4.1.2.5 China: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.3.4.2 Japan: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.2.1 Japan: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.2.2 Japan: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.4.2.2.1 Japan: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.4.2.2.2 Japan: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.4.2.2.3 Japan: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.4.2.2.4 Japan: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.4.2.2.5 Japan: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.3.4.3 India: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.3.1 India: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.3.2 India: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.4.3.2.1 India: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.4.3.2.2 India: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.4.3.2.3 India: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.4.3.2.4 India: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.4.3.2.5 India: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.3.4.4 Australia: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.4.1 Australia: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.4.2 Australia: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.4.4.2.1 Australia: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.4.4.2.2 Australia: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.4.4.2.3 Australia: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.4.4.2.4 Australia: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.4.4.2.5 Australia: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.3.4.5 South Korea: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.5.1 South Korea: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.5.2 South Korea: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.4.5.2.1 South Korea: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.4.5.2.2 South Korea: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.4.5.2.3 South Korea: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.4.5.2.4 South Korea: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.4.5.2.5 South Korea: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.3.4.6 Rest of Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.6.1 Rest of Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.3.4.6.2 Rest of Asia Pacific: Insulin Market, by Type, 2019–2028 (US$ Million)

8.3.4.6.2.1 Rest of Asia Pacific: Insulin Market, by Long Acting Insulin, 2019–2028 (US$ Million)

8.3.4.6.2.2 Rest of Asia Pacific: Insulin Market, by Rapid Acting Insulins, 2019–2028 (US$ Million)

8.3.4.6.2.3 Rest of Asia Pacific: Insulin Market, by Short Acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.3.4.6.2.4 Rest of Asia Pacific: Insulin Market, by Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.3.4.6.2.5 Rest of Asia Pacific: Insulin Market, by Biosimilar Insulins, 2019–2028 (US$ Million)

8.4 Middle East & Africa Insulin Market Revenue and Forecasts To 2028

8.4.1 Overview

8.4.2 Middle East & Africa Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.3 Middle East & Africa : Insulin Market, By Type, 2019–2028 (US$ Million)

8.4.3.1 Middle East & Africa : Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.4.3.2 Middle East & Africa : Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.4.3.3 Middle East & Africa : Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.4.3.4 Middle East & Africa : Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.4.3.5 Middle East & Africa : Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.4.4 Middle East & Africa Insulin Market Revenue and Forecast to 2028, by Country (%)

8.4.4.1 UAE: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.1.1 UAE: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.1.2 UAE: Insulin Market, By Type, 2019–2028 (US$ Million)

8.4.4.1.2.1 UAE: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.4.4.1.2.2 UAE: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.4.4.1.2.3 UAE: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.4.4.1.2.4 UAE: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.4.4.1.2.5 UAE: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.4.4.2 Saudi Arabia: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.2.1 Saudi Arabia: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.2.2 Saudi Arabia: Insulin Market, By Type, 2019–2028 (US$ Million)

8.4.4.2.2.1 Saudi Arabia: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.4.4.2.2.2 Saudi Arabia: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.4.4.2.2.3 Saudi Arabia: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.4.4.2.2.4 Saudi Arabia: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.4.4.2.2.5 Saudi Arabia: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.4.4.3 South Africa: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.3.1 South Africa Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.3.2 South Africa: Insulin Market, By Type, 2019–2028 (US$ Million)

8.4.4.3.2.1 South Africa: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.4.4.3.2.2 South Africa: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.4.4.3.2.3 South Africa: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.4.4.3.2.4 South Africa: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.4.4.3.2.5 South Africa: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.4.4.4 Rest of Middle East & Africa: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.4.1 Rest of Middle East & Africa: Insulin Market Revenue and Forecast to 2028 (US$ Million)

8.4.4.4.2 Rest of Middle East & Africa: Insulin Market, By Type, 2019–2028 (US$ Million)

8.4.4.4.2.1 Rest of Middle East & Africa: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.4.4.4.2.2 Rest of Middle East & Africa: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.4.4.4.2.3 Rest of Middle East & Africa: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.4.4.4.2.4 Rest of Middle East & Africa: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.4.4.4.2.5 Rest of Middle East & Africa: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.5 South and Central America Insulin Market Revenue and Forecasts To 2028

8.5.1 Overview

8.5.2 South and Central America: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.3 South and Central America: Insulin Market, By Type, 2019–2028 (US$ Million)

8.5.3.1 South and Central America: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.5.3.2 South and Central America: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.5.3.3 South and Central America: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.5.3.4 South and Central America: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.5.3.5 South and Central America: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.5.4 South and Central America Insulin Market Revenue and Forecast to 2028, by Country (%)

8.5.4.1 Brazil: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.4.1.1 Brazil: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.4.1.2 Brazil: Insulin Market, By Type, 2019–2028 (US$ Million)

8.5.4.1.2.1 Brazil: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.5.4.1.2.2 Brazil: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.5.4.1.2.3 Brazil: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.5.4.1.2.4 Brazil: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.5.4.1.2.5 Brazil: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.5.4.2 Argentina: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.4.2.1 Argentina: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.4.2.2 Argentina: Insulin Market, By Type, 2019–2028 (US$ Million)

8.5.4.2.2.1 Argentina: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.5.4.2.2.2 Argentina: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.5.4.2.2.3 Argentina: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.5.4.2.2.4 Argentina: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.5.4.2.2.5 Argentina: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.5.4.3 Rest of South and Central America: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.4.3.1 Rest of South and Central America: Insulin Market – Revenue and Forecast to 2028 (USD Million)

8.5.4.3.2 Rest of South and Central America: Insulin Market, By Type, 2019–2028 (US$ Million)

8.5.4.3.2.1 Rest of South and Central America: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.5.4.3.2.2 Rest of South and Central America: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.5.4.3.2.3 Rest of South and Central America: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.5.4.3.2.4 Rest of South and Central America: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.5.4.3.2.5 Rest of South and Central America: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

9. Impact of COVID-19 Pandemic on Global Insulin Market

9.1 North America: Impact Assessment of COVID-19 Pandemic

9.2 Europe: Impact Assessment of COVID-19 Pandemic

9.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

9.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

9.5 South and Central America: Impact Assessment of COVID-19 Pandemic

10. Insulin Market–Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Insulin Market (%)

10.3 Organic Developments

10.3.1 Overview

10.4 Inorganic Developments

10.4.1 Overview

11. Company Profile

11.1 Eli Lilly and Company

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Novo Nordisk A/S

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Biocon

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 WOCKHARDT

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Adocia

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 GlaxoSmithKline plc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Sanofi

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Pfizer Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Merck & Co., Inc.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Tonghua Dongbao Pharmaceutical Co., Ltd.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

11.11 BIGFOOT BIOMEDICAL, INC.

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Products and Services

11.11.4 Financial Overview

11.11.5 SWOT Analysis

11.11.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. North America: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 3. North America: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 4. North America: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 5. North America: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 6. North America: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 7. US: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 8. US: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 9. US: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 10. US: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million) 97

Table 11. US: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 12. US: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada: Insulin Market , By Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 15. Canada: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 17. Canada: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 18. Canada: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 21. Mexico: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 22. Mexico: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 23. Mexico: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 24. Mexico: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 26. Europe: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 27. Europe: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 28. Europe: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 29. Europe: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 30. Europe: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 31. Germany: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 32. Germany: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 33. Germany: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 34. Germany: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 35. Germany: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 36. Germany: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 37. France: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 38. France : Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 39. France : Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 40. France : Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 41. France : Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 42. France : Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 43. UK: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 44. UK: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 45. UK: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 46. UK: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 47. UK: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 48. UK: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 49. Italy: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 50. Italy: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 51. Italy: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 52. Italy: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 53. Italy: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 54. Italy: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 55. Spain: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 56. Spain: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 57. Spain: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 58. Spain: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 59. Spain: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 60. Spain: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 61. Rest of Europe: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 62. Rest of Europe: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 63. Rest of Europe: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 64. Rest of Europe: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 65. Rest of Europe: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 66. Rest of Europe: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 67. Asia Pacific: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 68. Asia Pacific: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 69. Asia Pacific: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 70. Asia Pacific: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 71. Asia Pacific: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 72. Asia Pacific: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 73. China: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 74. China: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 75. China: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 76. China: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 77. China: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 78. China: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 79. Japan: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 80. Japan: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 81. Japan: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 82. Japan: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 83. Japan: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 84. Japan: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 85. India: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 86. India: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 87. India: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 88. India: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 89. India: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 90. India: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 91. Australia: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 92. Australia: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 93. Australia: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 94. Australia: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 95. Australia: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 96. Australia: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 97. South Korea: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 98. South Korea: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 99. South Korea: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 100. South Korea: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 101. South Korea: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 102. South Korea: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 103. Rest of Asia Pacific: Insulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 104. Rest of Asia Pacific: Insulin Market, by Long Acting Insulin – Revenue and Forecast to 2028 (US$ Million)

Table 105. Rest of Asia Pacific: Insulin Market, by Rapid Acting Insulins – Revenue and Forecast to 2028 (US$ Million)

Table 106. Rest of Asia Pacific: Insulin Market, by Short Acting Insulins and Traditional Human Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 107. Rest of Asia Pacific: Insulin Market, by Concentrated Insulins and Combination Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 108. Rest of Asia Pacific: Insulin Market, by Biosimilar Insulins– Revenue and Forecast to 2028 (US$ Million)

Table 109. Middle East & Africa : Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 110. Middle East & Africa : Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 111. Middle East & Africa : Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 112. Middle East & Africa : Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 113. Middle East & Africa : Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 114. Middle East & Africa : Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 115. UAE: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 116. UAE: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 117. UAE: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 118. UAE: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 119. UAE: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 120. UAE: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 121. Saudi Arabia: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 122. Saudi Arabia: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 123. Saudi Arabia: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 124. Saudi Arabia: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 125. Saudi Arabia: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 126. Saudi Arabia: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 127. South Africa: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 128. South Africa: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 129. South Africa: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 130. South Africa: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 131. South Africa: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 132. South Africa: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 133. Rest of Middle East & Africa: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 134. Rest of Middle East & Africa: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 135. Rest of Middle East & Africa: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 136. Rest of Middle East & Africa: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 137. Rest of Middle East & Africa: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 138. Rest of Middle East & Africa: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 139. South and Central America: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 140. South and Central America: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 141. South and Central America: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 142. South and Central America: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 143. South and Central America: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 144. South and Central America: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 145. Brazil: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 146. Brazil: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 147. Brazil: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 148. Brazil: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 149. Brazil: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 150. Brazil: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 151. Argentina: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 152. Argentina: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 153. Argentina: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 154. Argentina: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 155. Argentina: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 156. Argentina: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 157. Rest of South and Central America: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 158. Rest of South and Central America: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 159. Rest of South and Central America: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 160. Rest of South and Central America: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 161. Rest of South and Central America: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 162. Rest of South and Central America: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 163. Organic Developments in the Insulin Market

Table 164. Inorganic Developments in the Insulin Market

Table 165. Glossary of Terms, Insulin Market

LIST OF FIGURES

Figure 1. Insulin Market Segmentation

Figure 2. Insulin Market Segmentation, By Region

Figure 3. Global Insulin Market Overview

Figure 4. The Long Acting Insulin Segment Held Largest Share of Type in the Insulin Market

Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Global Insulin Market, By Geography (US$ Million)

Figure 7. Global Insulin Market- Leading Country Markets (US$ Million)

Figure 8. Global Insulin Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East & Africa PEST Analysis

Figure 13. South & Central America PEST Analysis

Figure 14. Expert Opinion

TABLE 1. PREVALENCE OF DIABETES WORLDWIDE, 2021

Figure 15. Insulin Market Impact Analysis of Drivers and Restraints

Figure 16. Global Insulin Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 17. Global Insulin Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 18. Global Insulin Market – Market Potential Analysis, By Region

Figure 19. Market Positioning of Key Players In Global Insulin Market

Figure 20. Global Insulin Market – Comparative Company Analysis

Figure 21. Global Insulin Market – Growth Strategy Analysis

Figure 22. Insulin Market Revenue Share, by Type (2021 and 2028)

Figure 23. Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. North America Insulin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 50. North America Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 51. North America: Insulin Market, by Country, 2021 & 2028 (%)

Figure 52. US: Insulin market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. Canada: Insulin market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. Mexico: Insulin market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. Europe: Insulin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 56. Europe Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 57. Europe: Insulin Market, by Country, 2021 & 2028 (%)

Figure 58. Germany: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. France: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. UK: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61. Italy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 62. Spain: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 63. Rest of Europe: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64. Asia Pacific: Insulin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 65. Asia Pacific: Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 66. Asia Pacific: Insulin Market, by Country, 2022 & 2028 (%)

Figure 67. China: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 68. Japan: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 69. India: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 70. Australia: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 71. South Korea: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 72. Rest of Asia Pacific: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 73. Middle East & Africa Insulin Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 74. Middle East & Africa Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 75. Middle East & Africa Insulin Market Revenue and Forecast to 2028, by Country (%)

Figure 76. UAE: Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 77. Saudi Arabia: Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 78. South Africa: Insulin Market Revenue and Forecast to 2028 (US$ Million)

Figure 79. Rest of Middle East & Africa: Insulin MarketRevenue and Forecast to 2028 (US$ Million)

Figure 80. South and Central America Insulin Market Revenue Overview, By Country (2021) (US$ Mn)

Figure 81. South and Central America Insulin Market Revenue and Forecast to 2028 (USD Million)

Figure 82. South and Central America Insulin Market Revenue and Forecast to 2028, by Country (%)

Figure 83. Brazil: Insulin Market – Revenue and Forecast to 2028 (USD Million)

Figure 84. Argentina: Insulin Market – Revenue and Forecast to 2028 (USD Million)

Figure 85. Rest of South and Central America: Insulin Market – Revenue and Forecast to 2028 (USD Million)

Figure 86. Impact Of COVID-19 Pandemic in North American Country Markets

Figure 87. Impact Of COVID-19 Pandemic in Europe Country Markets

Figure 88. Impact of COVID-19 Pandemic in Asia Pacific Countries

Figure 89. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets

Figure 90. Impact of COVID-19 Pandemic in South and Central American Countries

Figure 91. Growth Strategies in the Insulin Market (%)

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.